Background The current study investigates circulating eosinophils and neutrophils in Alzheimer′s (AD) type dementia with respect to density (kg/L). The existence of b-amyloid plaques in the brain is a feature of AD. Sporadic scientific reports indicate that the disease affects circulating neutrophils. In contrast, numerous publications investigate inflammatory reactions in AD brains. Locally, the plaques evoke a substantial inflammatory response involving activated microglia and astrocytes.
Introduction
Outside the brain granulocytes, that is eosinophils and neutrophils are the first phagocytes to be in contact with invading bacteria. The cells then produce reactive oxygen intermediates of use in microbial killing. When activated, granulocytes also release a striking array of proteolytic enzymes. Examples include elastase and myeloperoxidase [1] . The blood-brain barrier safeguards the brain from the remainder of the body. In the brain, the immune system comprises of microglia, that is, resident brain macrophages believed to be the local representative of the monocyte-macrophage lineage [2] . Furthermore, in the cerebral cortex, astrocytes perform many functions associated with the immune response. The latter cells have phagocytic properties, and they are constituents of the blood-brain barrier.
The prevalence of Alzheimer dementia (AD) is escalating. Today, the pathogenesis of the disease eludes our comprehension. Senile plaques, that is, insoluble amyloid deposits in critical regions of the cerebral cortex are hallmarks of AD. The final diagnosis is dependent on post-mortem demonstration of amyloid plaques in the brain. The toxic self-aggregating b-amyloid peptides, the key constituent of the plaques, arise through proteolysis of the ubiquitous b-amyloid precursor protein [3] . To date, no reasonable experimental data have shown a connection between amyloid plaques and the recruitment of neutrophils to the brain. However, activated microglia and astrocytes surround the amyloid plaques [4] . The latter cells are major sources of oxidizing radical species causing local cell damage [5] .
AD-type dementia is associated with a substantial elevation of oxidative stress levels in circulating neutrophils [6] . The cells further contain b-amyloid peptides in their phagocytic granule [7] . Myeloperoxidase a myeloid-specific agent is found in amyloid plaques [8] . In dementia, surface expression of adhesion molecules on neutrophils is increased [9] . In the periphery, 
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phagocytosis of b-amyloid-peptides is defective [10] and even in early stages of the disease, granulocyte ability to engulf microbes is impaired [11] . Together these findings leave the door open for a potential role of granulocytes in AD pathophysiology.
In early disease, it is difficult to distinguish AD from other conditions causing memory impairments. Easy accessible biomarkers are necessary both for diagnosis and for precise classification of dementia according to latest diagnostic criteria. Previous communications from our laboratory present an approach to separate cells according to density [12] [13] [14] [15] . The AD disease process appears to be associated with density alterations of cells such as erythrocytes [16] and platelets [17] . The results make us suspect that AD is deleterious to circulating blood cells [16, 17] . The intention of this work is to find features of circulating granulocytes, that is, eosinophils and neutrophils being characteristic for AD.
Material and methods
All patients and/or responsible parties gave informed consent to participate. The local ethical committee approved the study protocol. Thirty-nine AD patients (19 females) (age 70 AE 8(SD) years) and 22 elderly (12 females) lacking obvious memory problems (age 66 AE 9(SD) years) were investigated. Table 1 shows demographic characteristics. Experienced geriatricians set the AD diagnosis, and we did not apply specific exclusion criteria. However, as shown in Fig. 1 , the demented group with a high degree of certainty contains mixed form of dementia as well. We separated granulocytes according to density (kg/L) into 16 different fractions. Previous publications describe the procedure in details [12] [13] [14] [15] . In all fractions, determination of eosinophil and neutrophil counts was carried out electronically. We employed the chi-square test and the Student's t-test for statistical evaluation. Reporting of the present study conforms to current guidelines [18] . Figures 1(a, b) (eosinophils) and 2(a, b) (neutrophils) give the distribution of cells in the density gradient. It is evident that AD-type dementia is associated with less low-density granulocytes. For the light fractions nos. 13-15, the P-values were (P < 0Á001; not significant; P = 0Á03) and (P = 0Á01; P = 0Á01; not significant), for eosinophils and neutrophils, respectively.
Results

Discussion
This study investigates granulocyte density alterations of circulating eosinophils and neutrophils in AD dementia sufferers. Abundant evidence indicates active inflammatory processes in AD. However, science dedicated to peripheral granulocytes in AD is sparse. To our knowledge, the behaviour of eosinophils in AD has not been investigated previously. In contrast, in AD-type dementia, extensive scientific work is devoted to inflammation in the central nervous system. The toxic substance b-amyloid triggers responses of microglia and astrocytes, and activated inflammatory cells are a feature of senile plaques.
Earlier publications describe the density gradient employed for separating granulocytes according to density extensively [12 -17] . For each density fraction, we determined the mean values for the 39 AD patients and the 22 controls with respect to granulocyte numbers. Subsequently, we employed the Student's t-test to calculate differences between means. It is likely that some of the significant disparities between groups are due to chance alone. However, with respect to light granulocyte populations, both cell lines demonstrate multiple significant differences close to each other. It is, thus, to assume that AD is associated with a decreased number of light granulocytes (Figs 1 and 2) . In health, activated platelet populations circulate degranulated [15] . It is to hypothesize that granulocytes activate in the circulation as well. They then lose granule and density subse-quently declines. It is to theorize that AD diminishes this putative mechanism and that the current results are indicative of impaired granulocyte turnover. It may be a sign of less cell functionality in AD-type dementia. The data encourage future research with respect to circulating granulocytes in AD. the research. We acknowledge grants from the Swedish Board 
